Procainamide
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Procainamide and local guidelines before prescribing.
Class Ia antiarrhythmic
Mechanism
Class Ia sodium-channel blocker.
Uses
Ventricular arrhythmia, pre-excited AF (alternative).
Dosing
- If unsuccessful: Amiodarone 300 mg IV over 10–20 minutes (or procainamide), then repeat cardioversion. Follow with amiodarone 900 mg over 24 hours.
Cardiology: Cardiology Emergencies - Amiodarone 300 mg IV over 10–60 minutes (preferably via a central line), then 900 mg over 24 hours. Procainamide is an alternative (ERC/RCUK 2025).
Cardiology: Cardiology Emergencies - Stable monomorphic VT: RCUK March 2026 favours synchronised cardioversion for most; if sedation risks are high, expert-guided procainamide 10–15 mg/kg IV over 20 min (maximum 1 g), or amiodarone 300 mg IV over 10–60 min followed by 900 mg over 24 h when procainamide unsuitable.
Cardiology: Cardiac Arrhythmias - Unstable tachyarrhythmia: Synchronised cardioversion up to 3 attempts; appropriate sedation/anaesthesia when conscious. If unsuccessful give amiodarone 300 mg IV over 10–20 min OR procainamide 10–15 mg/kg (maximum 1 g) over 20 min and repeat shock.
Cardiology: Cardiac Arrhythmias
2 more dose entries from the chapters
- Amiodarone Stable monomorphic VT alternative | 300 mg IV over 10–60 min, then 900 mg IV over 24 h when procainamide unsuitable and expert advice supports.
Cardiology: Cardiac Arrhythmias - Procainamide Selected VT | 10–15 mg/kg IV over 20 min (maximum 1 g); specialist monitoring, local availability and contraindications matter.
Cardiology: Cardiac Arrhythmias
Side effects
Hypotension, QT prolongation, drug-induced lupus, agranulocytosis.
Interactions
Amiodarone and QT-prolonging drugs increase proarrhythmia.
Contraindications and cautions
Heart block, SLE, long QT
Monitoring
ECG, BP, ANA, FBC
Pregnancy and breastfeeding
Use if essential
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Supportive; sodium bicarbonate
Special advice
Slow IV infusion with BP monitoring.
More from the textbook: uses, cautions and other points
- Important examples : Gene Drug Effect TPMT (and NUDT15) Azathioprine, mercaptopurine Low activity → severe bone marrow suppression - test before starting DPYD 5-fluorouracil, capecitabine Deficiency → severe, potentially fatal toxicity - test before starting (UK standard) HLA-B*57:01 Abacavir (HIV) Hypersensitivity reaction - test before …
Clinical pharmacology and prescribing: Principles of clinical pharmacology - Ia | Sodium channel block, prolong repolarisation - quinidine, procainamide, disopyramide | Rarely used; QT prolongation
Cardiology: Anatomy Physiology and Pharmacology - ⚠️ Safety Pearl: Very fast, irregular, broad-complex AF in a young person suggests pre-excited AF (WPW) . Do not give AV nodal blockers (adenosine, verapamil, diltiazem, digoxin, beta-blockers) - they can push conduction down the accessory pathway and cause VF. Use DC cardioversion (or specialist drugs such as procainamide).
Cardiology: Cardiology Emergencies - Pre-excited AF: Urgent specialist help; electrical cardioversion if unstable; procainamide may be considered in selected stable patients.
Cardiology: Cardiac Arrhythmias - Drugs causing lupus-like pleurisy (hydralazine, procainamide, isoniazid) | Pleuritis and effusions
Respiratory: Anatomy, Physiology and Pharmacology - Lichenoid , acneiform (steroids, lithium, EGFR inhibitors), pigmentary (amiodarone, minocycline), drug-induced lupus (hydralazine, procainamide, isoniazid, minocycline, anti-TNF), psoriasis flare (lithium, beta-blockers).
Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies - Drugs - hydralazine , procainamide , isoniazid , minocycline, methyldopa, quinidine, anti-TNF drugs , terbinafine, carbamazepine, phenytoin.
Rheumatology: Connective tissue diseases - Drug-induced lupus - hydralazine, procainamide, isoniazid, anti-TNF; anti-histone; spares kidneys and brain.
Rheumatology: Connective tissue diseases
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: Cardiology Emergencies (3 mentions)
- Cardiology: Cardiac Arrhythmias (5 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Rheumatology: Connective tissue diseases (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical Immunology: Autoimmunity, autoantibodies and complement (1 mention)
- Integrated cardiology chapter (5 mentions)
- Pathology: Immunopathology, amyloidosis, genetic and environmental disease (1 mention)